H012 Pill - yellow round
Pill with imprint H012 is Yellow, Round and has been identified as Lamotrigine Extended-Release 100 mg. It is supplied by Wilshire Pharmaceuticals, Inc.
Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for H012
Lamotrigine Extended-Release
- Imprint
- H012
- Strength
- 100 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wilshire Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 52536-0252 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
mannitol,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
magnesium silicate,
titanium dioxide,
triethyl citrate,
D&C Yellow No. 10,
FD&C Yellow No. 6,
aluminum oxide
Note: Inactive ingredients may vary.
Related images for "H012"
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,843)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.